PUBLISHER: Grand View Research | PRODUCT CODE: 1869858
PUBLISHER: Grand View Research | PRODUCT CODE: 1869858
The global transdermal skin patches market size was valued at USD 6.20 billion in 2024 and is projected to reach USD 9.55 billion by 2030, growing at a CAGR of 7.6% from 2025 to 2030. The market is increasing due to the growing incidence of chronic diseases such as cardiovascular disease, diabetes, chronic pain, etc., the enhanced preference of consumers for less-invasive treatment options, an aging population worldwide, and the technological advancement in transdermal drug delivery methods.
Transdermal patches offer a non-invasive and convenient approach to managing drugs through oral and injectable formulations; therefore, patients are more likely to take their medications as prescribed and experience lower gastrointestinal side effects than oral medications. Due to their ease of use and consistent drug-release rates over long periods, transdermal patches are especially appealing in chronic disease state management.
The industry is experiencing notable growth because of the rise of chronic diseases across the globe. In February 2024, the Centers for Disease Control and Prevention (CDC) estimates there are 129 million people in the United States with at least one key chronic disease, such as cancer, heart disease, obesity, diabetes, and hypertension. The most common treatment for chronic pain is to have the patient take pain relief medication daily, which is not only tedious, but oral or injectable forms often have bothersome side effects and burdensome frequency of administration. Transdermal patches can show efficacy in these scenarios as they improve adherence to medication therapy through regulated medication delivery over a longer period. For example, fentanyl transdermal patches have been approved for chronic pain management and will continuously release fentanyl over 72 hours, providing low-dose relief and reducing the frequency of administration.
Innovations like microneedles, iontophoresis, and permeation enhancers have broadened the transdermal drug delivery landscape, creating new possibilities for administering large molecules and biologics. Microneedle patches generate tiny channels to the skin to enhance the delivery of large-molecule drugs that are too large to administer transdermally. For instance, a microneedle patch containing insulin allows for a pain-free way of taking insulin rather than daily needles, which may optimize control of glycemic levels. Iontophoresis is a newer, innovative delivery strategy that utilizes a small electric charge to help push drugs through the skin.
Global Transdermal Skin Patches Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and analyzes the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global transdermal skin patches market report by type, application, distribution channel, and region: